Ziftomenib Displays Early-Phase Efficacy in Relapsed or Refractory AML
Investigators of the phase 1/2 KOMET-001 trial are seeking to address unmet needs in AML with the investigational menin inhibitor ziftomenib.
Source: onclive.com
Page 23 - Accessed May News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Accessed May Today - Breaking & Trending Today
FDA Approves Brixadi, a New Treatment Option for Opioid Use Disorder
Brixadi (buprenorphine) is approved for patients with moderate to severe OUD who are already taking or have initiated transmucosal buprenorphine.
Source: clinicaladvisor.com
Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States
Only Eye Vitamin That Supports Two Health Benefits in One, Clinically Proven AREDS 2 Formula for Eye Health and 100 mg of CoQ10 Antioxidant for Heart Health* ... | June 12, 2023
Source: marketscreener.com
How to trim thickened toenails - Mayo Clinic
Thickened toenails can be uncomfortable, especially if they grow too long. Learn how best to trim them.
Source: mayoclinic.org
Optimizing Patient Visits: Implementing Immunizations Into the Ambulatory Clinic Workflow
Ambulatory care pharmacy residents play a major role in increasing both patient awareness about recommended vaccination and vaccination rates.
Source: pharmacytimes.com